- Mister Bind, the ligand: A ligand is a small molecule that acts like a key: it’s designed to find and stick to the right “lock” (the biological target) on a cell’s surface. In our stories, Mr. Bind plays this important role, helping treatments reach the right cells. For each pathology, specific ligands can be associated with receptors from the targeted cells and converted into a vector that will carry a radioisotope to this target.
- Dr. Dia (imaging) & Dr. Thera (therapy), the radioisotopes: A radioisotope is a special type of atom that gives off a tiny bit of energy over time. In medicine, it’s used to see inside the body (Dr Dia) or to deliver treatment directly to diseased cells (Dr. Tera), like cancer, with high precision. This Ligand can be converted into a vector that will carry a radioactive Atom to this target
- The biological target: A biological target is like a unique “flag” found on the surface of certain cells, especially cancer cells. These tiny flags help the cell grow, divide, or absorb nutrients. Scientists use them to spot and treat unhealthy cells.
- The cancer cell: A cancer cell is a cell that stops following the rules. Instead of growing, dividing, and dying when it should, it keeps multiplying uncontrollably. Over time, these rebellious cells can form lumps (tumors) or spread to other parts of the body, making people sick.
Patient support
By our mission, we aim to support people living with cancer by sharing clear, reliable information about radiotheranostics and its role in treatment, but also to help them navigate through this journey and guide them every step of the way.
Here, you'll find resources and practical guidance to understand this therapy and locate centers that offer radioligand treatment.
More patient education leads to improved access, and no one should face cancer alone.
Meet Mister Bind and his companions to learn more about Radioligand therapy!
Mister Bind and his companions are an interactive support developed to answer the need for support in explaining the technology of radiotheranostics to newly diagnosed cancer patients and their families.
Part 1What are radiotheranostics for cancer care?
Part 2Doctor, will radiotheranostics make me radioactive?
How does Radioligand therapy work?
Precisely target a biological entity that is specific for one tissue, one type of cell, or one organ (e.g., a tumor cell).
Depending on the type of emitted Radiation (rays or particles), the Atom (Radionuclide) will act as:
- A tracer, i.e., an Imaging (diagnosis) agent, Dr. Dia, emitting a signal from the target-bound tissue
OR
- A drug, i.e., a therapeutic agent, Dr. Thera, destroying the targeted cells
"Treating what we see, seeing what we treat"
- Destroy cancer cells with minimum damage to healthy tissues
- Potential to reduce the risk of side effects
- May improve the quality of life during and after treatment
- Alternative option for recurrent disease
RLT Channel:
Bringing Radiotheranostics
to the Forefront of Cancer Care
The RLT Channel is offering a recurring platform to spotlight various cancers and explore their treatment possibilities through radiotheranostics.
Each program is designed to provide comprehensive insights, from addressing global challenges to highlighting local perspectives and advancements.
EN - EP01: Prostate Cancer’s New Hope: RLT in Action - Global focus
FR - EP01: Nouvel espoir pour le cancer de la prostate : La RLT en Action - Focus Belgique
Which cancers can Radioligand Therapy treat?
Radioligand Therapy is already used to treat several types of cancer.
Learn how effective it is and how it works for each specific cancer.
+1000
Therapy centers
Find your nearest treatment center!
With over 1,000 therapy centers worldwide, this interactive global map is designed ti help you find where Radioligand therapies are available. Explore the map to locate specialized centers offering these advanced treatments, bringing you one step closer to accessing the care you need.
Treatment
Donation
RTL-connect: A global treatment program for patients in financial need.
RLT- Connect is a collaborative platform established by the Oncidium foundation to facilitate access to Radioligand Therapy (RLT) for cancer patients who cannot afford them as the treatment is not yet reimbursed.
Clinical Trials
At the Oncidium foundation, we believe clinical trials open the door to tomorrow's cancer therapies.
We provide people living with cancer with the latest information on radiotheranostics and guide them to treatment centers and clinical studies that match their diagnosis.
By connecting patients with these state-of-the-art trials, we help advance new breakthroughs and ensure they can access the very best care options available.
Stories of hope
Discover inspiring stories of people living with cancer and learn about radioligand therapy is helping them regain control over their lives.
